HIF1A and hepatocellular carcinoma: As shown in Figures 2D–I and Tables 1, 2, the prognosis of advanced HCC patients with low FBI-1 (Figures 2D, –F) or HIF-1α (Figures 2G, –I) levels was much better compared with the patients with high levels of FBI-1 or HIF-1α: the TTP and OS of the high FBI-1 or HIF-1α group were shorter compared to that of the low FBI-1 or HIF-1α group (Tables 1, 2).